NASDAQ: SAGE       Sage Therapeutic Com
Last Price Today's Change   Day's Range   Trading Volume
92.44   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):503,741
4 Weeks Range:83.63 - 98.39
4 Weeks Price Volatility (%):
52 Weeks Range:25.01 - 98.39
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. Sage's lead development program is SAGE-547, it is in Phase 3 clinical trials for super-refractory status epilepticus; and the SAGE-217 program which is in Phase 2 clinical trials for post-partum depression, essential tremor, Parkinson's disease and major depressive disorder. The company is also developing several other compounds for treatment that is in the early stage of development.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3708  2604  332  3248 

Top 10 Active Counters
 ADMP 1.75+0.48 
 LK 1.38+1.38 
 CTRM 0.397-0.028 
 WPX 9.43+0.48 
 SNDL 0.632-0.029 
 NIO 61.113+2.773 
 F 11.425-0.105 
 BNGO 9.519+1.249 
 AZRX 1.981+0.741 
 OBLN 6.008+0.818